Integrated Medical Sensors

Irvine, CA · Medtech · Private

Wireless electrochemical continuous metabolic monitoring (CMM) sensor platform using CMOS ASIC technology for simultaneous glucose, lactate, and temperature sensing

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Medtech
Headquarters
Irvine, CA
Total capital
$4.7M
Federal grants
$4.7M
11 awards · 2016–2025
Rank in peer group#126 of 538
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
4
5 pending · first 2023
Rank in peer group#125 of 538

Capital timeline

20162018202020222024FEDERAL ↑EQUITY ↓Cumulative $4.7M$1.5M$706K$400K$350K$285K$275K
20162018202020222024FEDERAL ↑EQUITY ↓Cumulative $4.7M$1.5M$706K$400K$350K

Latest events

  • Federal grantHealth and Human S · Phase I · A Miniaturized and Flexible Continuous Glucose Monitoring Platform$275K
  • Federal grantHealth and Human S · Phase I · Development and Validation of Efficient Algorithms for Real-Time Glucose Monitoring on a Multi-Sensor Integrated Platform$285K
  • Federal grantHealth and Human S · Phase I · A Miniaturized and Integrated Continuous Metabolic Monitoring Platform$350K
  • Federal grantHealth and Human S · Phase I · A Smart Semiconductor based Integrated Continuous Diabetes Monitoring Platform$400K
  • Federal grantNSF · Phase I · SBIR Phase I:A novel multianalyte microsensor platform for continuous wireless monitoring applications$256K
  • Federal grantHealth and Human S · Phase II · An accurate, fast, and miniaturized glucose sensor for closed-loop diabetes management$706K
  • Federal grantHealth and Human S · Phase II · An accurate, fast, and miniaturized glucose sensor for closed-loop diabetes management$1.5M
Show 4 earlier federal awards
  • Federal grantHealth and Human S · Phase I · A reliable and accurate miniaturized wireless electrochemical glucose sensing solution for closed-loop diabetes management$250K
  • Federal grantHealth and Human S · Phase I · A Low-cost microscale implantable wireless glucose sensor for diabetes management$225K
  • Federal grantNSF · Phase I · SBIR Phase I: A miniaturized, low-cost, implantable wireless glucose sensor technology for Diabetes management$225K
  • Federal grantHealth and Human S · Phase I · An Integrated Sub-dermal Wireless Glucose Sensor - a Low-Cost Solution for Diabetes Management$225K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 538 peers

Line = median

Medtech · Device

  • Federal grants#126 · top 23%
  • Granted patents#125 · top 23%
  • Linked publications#59 · top 11%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 4 granted of 9
Show all 9 patent records

Recent research by its founders

  • 2897-LB: In Vivo Multiday Feasibility of a Semiconductor-Based CGM+CKM System20260 cites
  • An 800GbE PAM-4 PHY Transceiver that Supports 42dB Copper and Direct-Drive Optical Applications in 7nm20252 cites
  • 2025-LB: Feasibility of Long-Term Use of a Semiconductor-Based CGM+ System in Humans20251 cites

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .